Authors:
Sanchez, GI
Sedegah, M
Rogers, WO
Jones, TR
Sacci, J
Witney, A
Carucci, DJ
Kumar, N
Hoffman, SL
Citation: Gi. Sanchez et al., Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice, INFEC IMMUN, 69(6), 2001, pp. 3897-3905
Authors:
Gramzinski, RA
Doolan, DL
Sedegah, M
Davis, HL
Krieg, AM
Hoffman, SL
Citation: Ra. Gramzinski et al., Interleukin-12-and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice, INFEC IMMUN, 69(3), 2001, pp. 1643-1649
Authors:
Le, TP
Coonan, KM
Hedstrom, RC
Charoenvit, Y
Sedegah, M
Epstein, JE
Kumar, S
Wang, RB
Doolan, DL
Maguire, JD
Parker, SE
Hobart, P
Norman, J
Hoffman, SL
Citation: Tp. Le et al., Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers, VACCINE, 18(18), 2000, pp. 1893-1901
Authors:
Charest, H
Sedegah, M
Yap, GS
Gazzinelli, RT
Caspar, P
Hoffman, SL
Sher, A
Citation: H. Charest et al., Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8(+) T cell-dependent protective immunity against malarial, J IMMUNOL, 165(4), 2000, pp. 2084-2092
Authors:
Sedegah, M
Weiss, W
Sacci, JB
Charoenvit, Y
Hedstrom, R
Gowda, K
Majam, VF
Tine, J
Kumar, S
Hobart, P
Hoffman, SL
Citation: M. Sedegah et al., Improving protective immunity induced by DNA-based immunization: Priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus, J IMMUNOL, 164(11), 2000, pp. 5905-5912